TP53 and B-cell chronic lymphocytic leukemia: Furthermore, in chronic lymphocytic leukemia (CLL) [82], NQO1 gene variability has been associated with cytogenetic abnormalities and TP53 disruptions, suggesting its involvement in p53 pathway integrity.